Showing results (4401-4410 of 6,511) with videos related to
Sort By:
Pageof 652
Experimental Hematology|July 31, 2007
N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cellsHeidi Hemmoranta, Tero Satomaa, Maria Blomqvist, et al.Experimental Hematology|July 28, 2007
Cloning and characterization of a human BCR/ABL-positive cell line, K562/RR, resistant to the farnesyltransferase inhibition by tipifarnibTakuji Miyoshi, Tadashi Nagai, Satoru Kikuchi, et al.Experimental Hematology|July 28, 2007
CD133-enriched CD34(-) (CD33/CD38/CD71)(-) cord blood cells acquire CD34 prior to cell division and hematopoietic activity is exclusively associated with CD34 expressionKatharina S Götze, Matthias Schiemann, Stefanie Marz, et al.Experimental Hematology|May 30, 2007
Iron/IRP-1-dependent regulation of mRNA expression for transferrin receptor, DMT1 and ferritin during human erythroid differentiationJunji Kato, Masayoshi Kobune, Shunichi Ohkubo, et al.Experimental Hematology|May 30, 2007
N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiationSylvie Shen, Toby Passioura, Geoff Symonds, et al.Experimental Hematology|May 30, 2007
Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesisThomas A Widmann, Markus Herrmann, Naim Taha, et al.Experimental Hematology|May 30, 2007
Adiponectin binds to chemokines via the globular head and modulates interactions between chemokines and heparan sulfatesHiroaki Masaie, Kenji Oritani, Takafumi Yokota, et al.Experimental Hematology|December 1, 1991
Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitorsW Piacibello, D Ferrero, F Sanavio, et al.Experimental Hematology|December 1, 1991
Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitorsK Nakao, M Kosaka, S SaitoExperimental Hematology|May 27, 2006
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1Corinna Leng, Margarethe Gries, Judy Ziegler, et al.Pageof 652